These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Medical research involving children: some legal and ethical issues. Langer DH Bayl Law Rev; 1984; 36(1):1-39. PubMed ID: 11658558 [No Abstract] [Full Text] [Related]
25. Research involving children: an interpretation of the new regulations. Levine RJ IRB; 1983; 5(4):1-5. PubMed ID: 11649521 [No Abstract] [Full Text] [Related]
26. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986. Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693 [No Abstract] [Full Text] [Related]
27. Clinical trials face heightened scrutiny as science and commerce appear to merge. Lorman AJ J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494 [TBL] [Abstract][Full Text] [Related]
28. Justice and research design: the case for a semi-randomization clinical trial. Veatch RM Clin Res; 1983 Feb; 31(1):12-22. PubMed ID: 10299203 [No Abstract] [Full Text] [Related]
29. Law No. 88-1138 of 20 Dec 1988 on the Protection of Persons Participating in Biomedical Research. France Int Dig Health Legis; 1989; 40(1):109-13. PubMed ID: 11659174 [No Abstract] [Full Text] [Related]
30. Ethics of Research Involving Children: Proceedings of a National Workshop. National Council on Bioethics in Human Research (Canada) NCBHR Commun; 1993; 4(1):12-41. PubMed ID: 11659941 [No Abstract] [Full Text] [Related]
31. Ethical and human-rights issues in research on mental disorders that may affect decision-making capacity. Capron AM N Engl J Med; 1999 May; 340(18):1430-4. PubMed ID: 10228198 [No Abstract] [Full Text] [Related]
32. Ethical issues in clinical research. Informed consent and risks versus benefits in the treatment of primary hypertension. Fry ST Nurs Clin North Am; 1989 Dec; 24(4):1033-9. PubMed ID: 2685772 [TBL] [Abstract][Full Text] [Related]
33. The duty to exclude: excluding people at undue risk from research. Weijer C; Fuks A Clin Invest Med; 1994 Apr; 17(2):115-22. PubMed ID: 8004847 [TBL] [Abstract][Full Text] [Related]
34. Policies and quality assurance in the pharmaceutical industry. Shamoo AE Account Res; 1991; 1(4):273-84. PubMed ID: 11651459 [No Abstract] [Full Text] [Related]
35. Informed consent for a clinical trial in Thailand. Achrekar A; Gupta R N Engl J Med; 1998 Oct; 339(18):1331-2. PubMed ID: 9841301 [No Abstract] [Full Text] [Related]
36. Ethical considerations in research involving pregnant women. The American College of Obstetricians and Gynecologists. Womens Health Issues; 1999; 9(4):194-8. PubMed ID: 10405591 [No Abstract] [Full Text] [Related]
37. New federal rule on protecting children as research subjects. Maloney DM Hum Res Rep; 2001 Jun; 16(6):3. PubMed ID: 11785526 [No Abstract] [Full Text] [Related]
39. Points to consider for ethics committees in human gene therapy trials. Dettweiler U; Simon P Bioethics; 2001 Oct; 15(5-6):491-500. PubMed ID: 12058773 [TBL] [Abstract][Full Text] [Related]
40. Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trials. Kimmelman J; Levenstadt A Hum Gene Ther; 2005 Apr; 16(4):502-8. PubMed ID: 15871681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]